FDA to grant ‘voluntary action indicated’ classification to B+L

The FDA will issue a “voluntary action indicated” inspection classification for Valeant’s Bausch + Lomb manufacturing plant in Tampa, Florida, according to a company press release.This development will eliminate manufacturing uncertainties related to the facility’s regulatory submissions, the release said.

Full Story →